These inflammatory processes are accompanied by a dysregulated cytokine milieu, including elevated levels of IL-6, IL-17, and TNF-α, which are hallmarks of RA (Yan et al., 2023; Lei et al., 2023). This evidence concerns the gene IL17A and rheumatoid arthritis.